Arrowstreet Capital
STJ

Arrowstreet Capital’s St Jude Medical STJ Stock Holding History

Arrowstreet Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,400
Closed -$343K – 1740
2016
Q2 		$343K Sell
4,400
-150,364
-97% -$10.7M ﹤0.01% 1209
2016
Q1 		$8.51M Buy
154,764
+75,464
+95% +$4.11M 0.04% 410
2015
Q4 		$4.9M Buy
79,300
+72,800
+1,120% +$4.59M 0.02% 555
2015
Q3 		$410K Buy
+6,500
New +$464K ﹤0.01% 1134
2014
Q4 		– Sell
-6,522
Closed -$392K – 1404
2014
Q3 		$392K Buy
+6,522
New +$426K ﹤0.01% 873
2014
Q2 		– Sell
-5,225
Closed -$342K – 1315
2014
Q1 		$342K Buy
+5,225
New +$340K ﹤0.01% 1025

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowstreet Capital's STJ Position: Q3 2016 in Review

Arrowstreet Capital sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 4,400 shares — an estimated $343K sold.

Arrowstreet Capital first reported a position in STJ in Q1 2014 and held it in 6 quarters. The position peaked at $8.51M in Q1 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Arrowstreet Capital reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Arrowstreet Capital sold 4,400 St Jude Medical shares in Q3 2016, an estimated $343K.
  • Arrowstreet Capital first reported a position in St Jude Medical in Q1 2014 and held it in 6 quarters.
  • Arrowstreet Capital's St Jude Medical position peaked at $8.51M in Q1 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Arrowstreet Capital's 13F filing for Q3 2016, filed 14 Nov 2016.